Amyloid blood biomarker detects Alzheimer's disease

Alzheimer's disease (AD) is currently incurable, but there is general agreement that a minimally invasive blood biomarker for screening in preclinical stages would be crucial for future therapy. Diagnostic tools for detection of AD are either invasive like cerebrospinal fluid (CSF) biomarkers o...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabers, Andreas, Perna, Laura, Lange, Julia, Mons, Ute, Schartner, Jonas, Güldenhaupt, Jörn, Saum, Kai‐Uwe, Janelidze, Shorena, Holleczek, Bernd, Rujescu, Dan, Hansson, Oskar, Gerwert, Klaus, Brenner, Hermann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938617/
https://www.ncbi.nlm.nih.gov/pubmed/29626112
http://dx.doi.org/10.15252/emmm.201708763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938617/
https://www.ncbi.nlm.nih.gov/pubmed/29626112
http://dx.doi.org/10.15252/emmm.201708763

Ejemplares similares